4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-041961
Director sold 14,376 shares at an average $6.28 ($90,286)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bernard Gordon R Director | 2019-06-27 | Sale | −1,865 | $6.35 | $11,843 | 73,084 | D |
| Bernard Gordon R Director | 2019-06-28 | Sale | −2,324 | $6.37 | $14,804 | 70,760 | D |
| Bernard Gordon R Director | 2019-07-01 | Sale | −2,788 | $6.41 | $17,871 | 67,972 | D |
| Bernard Gordon R Director | 2019-07-02 | Sale | −2,802 | $6.36 | $17,821 | 65,170 | D |
| Bernard Gordon R Director | 2019-07-03 | Sale | −729 | $6.32 | $4,607 | 64,441 | D |
| Bernard Gordon R Director | 2019-07-05 | Sale | −668 | $6.31 | $4,215 | 63,773 | D |
| Bernard Gordon R Director | 2019-07-08 | Sale | −400 | $6.25 | $2,500 | 63,373 | D |
| Bernard Gordon R Director | 2019-07-09 | Sale | −500 | $6.11 | $3,055 | 62,873 | D |
| Bernard Gordon R Director | 2019-07-10 | Sale | −2,300 | $5.90 | $13,570 | 60,573 | D |
| Open-market sales · 14,376 sh · avg $6.28 · $90,286 | |||||||
Loading xslF345X03/doc4.xml…